Saranac Partners Ltd

Saranac Partners Ltd (CIK 0002098745) is a London-based independent wealth management and investment office serving ultra-high-net-worth individuals, families, entrepreneurs, and select institutions. Authorised and regulated by the UK Financial Conduct Authority, the firm provides discretionary portfolio management, advisory services, and consolidated reporting across liquid markets and private investments. Established in the mid‑2010s, Saranac Partners was set up as a private partnership with a focus on long-term client relationships, open‑architecture investment selection, and institutional‑grade portfolio construction for complex balance sheets. The firm combines in‑house investment management with manager selection, co‑investment opportunities, and access to specialist external strategies across public and private markets. Saranac Partners Ltd appears in U.S. regulatory filings as a Form 13F institutional investment manager because it exercises discretionary authority over U.S.-listed securities on behalf of its clients at levels that exceed the SEC reporting threshold. Form 13F reports under CIK 0002098745 aggregate the firm’s reportable long positions in U.S. equities and certain exchange‑traded products across applicable mandates. These filings provide a partial view into its global asset allocation, capturing only U.S.-listed equity exposures and omitting non‑U.S. securities, bonds, alternatives, and private assets that form a core part of the platform. Within an institutional analytics environment, this disclosure can be organised into a time series of portfolios to reconstruct Saranac’s U.S. 13F Portfolio Composition over time. That dataset acts as a support layer to the broader qualitative understanding of the firm as a multi‑asset wealth manager rather than as a dedicated U.S. equity fund.

Saranac Partners’ core proposition is multi‑asset wealth management tailored to the objectives, risk tolerance, and liquidity needs of sophisticated private clients. Strategic asset allocation is central: portfolios are designed to balance capital preservation with real wealth growth, blending listed equities, fixed income, cash, hedge funds, private equity, real assets, and thematic opportunities. Within listed markets, the firm typically emphasises high‑quality issuers and managers with robust balance sheets, sustainable cash flows, and strong governance. Equity exposures are implemented both directly—via single stocks in core geographies such as the U.S., UK, and Europe—and indirectly through specialist active managers and ETFs that provide access to regions, factors, or sectors where third‑party expertise is preferred. The result is an equity profile that is broadly diversified by sector and region but with discernible tilts toward structural growth themes and stable cash‑generative businesses. For U.S. securities specifically, which are captured in Form 13F, holdings usually span large‑ and mid‑cap names in sectors such as technology, healthcare, financials, consumer, and industrials, alongside broad and sector ETFs. Positioning in this sleeve is driven by a combination of top‑down asset allocation and bottom‑up security or manager selection within Saranac’s investment committee framework. Turnover in core allocations is generally low, reflecting a long‑term horizon, with more active adjustment at the margin driven by changes in client circumstances, risk appetite, or macro and valuation conditions. Tactical tilts—such as increasing defensive exposures, adjusting currency or regional balance, or rotating between growth and value styles—are implemented in a size that is proportionate to client risk profiles rather than as standalone trading strategies. Because Form 13F only captures part of the liquid equity toolkit, it misses key aspects of the firm’s multi‑asset design, including fixed income duration decisions, alternative investments, and private market commitments. Nevertheless, by passing the disclosed U.S. holdings through a Portfolio Simulator or Backtesting Service, allocators can derive a normalised Historical Track Record for the U.S. equity component under Saranac’s management, while recognising that this represents only one vector of a broader multi‑asset mandate.

Saranac Partners Ltd is an FCA‑authorised London wealth manager and investment office whose SEC presence under CIK 0002098745 reflects its role as an institutional manager of U.S.-listed securities within broader, bespoke client portfolios. The firm’s philosophy combines long‑term strategic asset allocation, an emphasis on quality and diversification, and selective use of direct securities and external managers across asset classes. By organising its 13F filings into a structured 13F Portfolio Composition, allocators can observe how Saranac’s U.S. equity exposures by sector, issuer, and instrument type have evolved across different market regimes. When these reconstructed portfolios are run through Performance Backtests Online or a similar Portfolio Simulator, they yield a proxy Historical Track Record for the U.S. sleeve, from which diagnostics such as an indicative Volatility Profile and Sharpe Ratio on normalised capital can be derived. Interpreted alongside qualitative due diligence on Saranac’s governance, client service model, and private‑market capabilities, these analytics provide a disciplined view of how the firm’s observable U.S. equity allocations contribute to overall capital trajectory and downside behaviour. The central diagnostic question for allocators is how this diversified, quality‑tilted U.S. equity sleeve—set within a multi‑asset framework—would respond under materially different market regimes, such as sustained higher real rates, prolonged style rotations, or extended equity stagnation, relative to the historical environment encoded in its disclosed holdings.

At the total‑portfolio level, Saranac Partners manages risk via strategic asset allocation, diversification across asset classes and currencies, and careful calibration of liquidity and drawdown tolerance to each client’s profile. Equity risk is balanced by defensive allocations to high‑quality credit, cash, and diversifying strategies across alternatives and private markets. Within the narrower confines of Form 13F data, the observable risk profile is that of the U.S. long‑equity sleeve embedded in client portfolios. Here, key risk drivers include: - Overall equity market beta to U.S. indices, reflecting broad participation in global large‑cap equities. - Sector and style tilts introduced by the mix of individual securities and ETFs—such as relative weights in technology and healthcare versus more cyclical or defensive sectors, and the balance between growth‑ and value‑oriented holdings. - Issuer concentration in the largest positions, particularly where core convictions or long‑term thematic holdings are expressed via single names rather than broad funds. Given Saranac’s wealth‑management orientation, the U.S. equity book is typically diversified enough to moderate idiosyncratic single‑name risk, even where certain positions are meaningful in size. Volatility in the 13F sleeve will generally echo major U.S. market moves, with some differentiation driven by sector tilts and manager selection. Client‑level drawdowns are ordinarily less severe than those of the equity sleeve alone because of the presence of fixed income, cash, and other diversifiers not visible in 13F filings. From an analytics standpoint, a reconstructed holdings series from the firm’s 13F History allows allocators to estimate an indicative Volatility Profile for the U.S. equity component on a user‑defined notional. Tracking this series through past market shocks also enables measurement of peak‑to‑trough losses and recovery paths, and supports calculation of an implied Sharpe Ratio that summarises risk‑adjusted outcomes for the observable sleeve. These metrics clarify how the firm’s U.S. equity implementation would have behaved if held exactly as reported, while leaving the full multi‑asset risk posture outside the 13F lens.